Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.

Dynamins are fission proteins that mediate endocytic and exocytic membrane events and are pharmacological therapeutic targets. These studies investigate whether dynamin II regulates constitutive protein secretion and show for the first time that pharmacological inhibition of dynamin decreases secret...

Full description

Bibliographic Details
Main Authors: Maaike Kockx, Denuja Karunakaran, Mathew Traini, Jing Xue, Kuan Yen Huang, Diana Nawara, Katharina Gaus, Wendy Jessup, Phillip J Robinson, Leonard Kritharides
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4210248?pdf=render
id doaj-10dd734f603c4905a989bc5ff4f243db
record_format Article
spelling doaj-10dd734f603c4905a989bc5ff4f243db2020-11-24T23:58:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e11118610.1371/journal.pone.0111186Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.Maaike KockxDenuja KarunakaranMathew TrainiJing XueKuan Yen HuangDiana NawaraKatharina GausWendy JessupPhillip J RobinsonLeonard KritharidesDynamins are fission proteins that mediate endocytic and exocytic membrane events and are pharmacological therapeutic targets. These studies investigate whether dynamin II regulates constitutive protein secretion and show for the first time that pharmacological inhibition of dynamin decreases secretion of apolipoprotein E (apoE) and several other proteins constitutively secreted from primary human macrophages. Inhibitors that target recruitment of dynamin to membranes (MiTMABs) or directly target the GTPase domain (Dyngo or Dynole series), dose- and time- dependently reduced the secretion of apoE. SiRNA oligo's targeting all isoforms of dynamin II confirmed the involvement of dynamin II in apoE secretion. Inhibition of secretion was not mediated via effects on mRNA or protein synthesis. 2D-gel electrophoresis showed that inhibition occurred after apoE was processed and glycosylated in the Golgi and live cell imaging showed that inhibited secretion was associated with reduced post-Golgi movement of apoE-GFP-containing vesicles. The effect was not restricted to macrophages, and was not mediated by the effects of the inhibitors on microtubules. Inhibition of dynamin also altered the constitutive secretion of other proteins, decreasing the secretion of fibronectin, matrix metalloproteinase 9, Chitinase-3-like protein 1 and lysozyme but unexpectedly increasing the secretion of the inflammatory mediator cyclophilin A. We conclude that pharmacological inhibitors of dynamin II modulate the constitutive secretion of macrophage apoE as a class effect, and that their capacity to modulate protein secretion may affect a range of biological processes.http://europepmc.org/articles/PMC4210248?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Maaike Kockx
Denuja Karunakaran
Mathew Traini
Jing Xue
Kuan Yen Huang
Diana Nawara
Katharina Gaus
Wendy Jessup
Phillip J Robinson
Leonard Kritharides
spellingShingle Maaike Kockx
Denuja Karunakaran
Mathew Traini
Jing Xue
Kuan Yen Huang
Diana Nawara
Katharina Gaus
Wendy Jessup
Phillip J Robinson
Leonard Kritharides
Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
PLoS ONE
author_facet Maaike Kockx
Denuja Karunakaran
Mathew Traini
Jing Xue
Kuan Yen Huang
Diana Nawara
Katharina Gaus
Wendy Jessup
Phillip J Robinson
Leonard Kritharides
author_sort Maaike Kockx
title Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
title_short Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
title_full Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
title_fullStr Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
title_full_unstemmed Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
title_sort pharmacological inhibition of dynamin ii reduces constitutive protein secretion from primary human macrophages.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Dynamins are fission proteins that mediate endocytic and exocytic membrane events and are pharmacological therapeutic targets. These studies investigate whether dynamin II regulates constitutive protein secretion and show for the first time that pharmacological inhibition of dynamin decreases secretion of apolipoprotein E (apoE) and several other proteins constitutively secreted from primary human macrophages. Inhibitors that target recruitment of dynamin to membranes (MiTMABs) or directly target the GTPase domain (Dyngo or Dynole series), dose- and time- dependently reduced the secretion of apoE. SiRNA oligo's targeting all isoforms of dynamin II confirmed the involvement of dynamin II in apoE secretion. Inhibition of secretion was not mediated via effects on mRNA or protein synthesis. 2D-gel electrophoresis showed that inhibition occurred after apoE was processed and glycosylated in the Golgi and live cell imaging showed that inhibited secretion was associated with reduced post-Golgi movement of apoE-GFP-containing vesicles. The effect was not restricted to macrophages, and was not mediated by the effects of the inhibitors on microtubules. Inhibition of dynamin also altered the constitutive secretion of other proteins, decreasing the secretion of fibronectin, matrix metalloproteinase 9, Chitinase-3-like protein 1 and lysozyme but unexpectedly increasing the secretion of the inflammatory mediator cyclophilin A. We conclude that pharmacological inhibitors of dynamin II modulate the constitutive secretion of macrophage apoE as a class effect, and that their capacity to modulate protein secretion may affect a range of biological processes.
url http://europepmc.org/articles/PMC4210248?pdf=render
work_keys_str_mv AT maaikekockx pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT denujakarunakaran pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT mathewtraini pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT jingxue pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT kuanyenhuang pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT diananawara pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT katharinagaus pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT wendyjessup pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT phillipjrobinson pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
AT leonardkritharides pharmacologicalinhibitionofdynaminiireducesconstitutiveproteinsecretionfromprimaryhumanmacrophages
_version_ 1725452414325096448